Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Mesothelioma, Malignant 14Solid Tumor 12Mesothelioma 12Unspecified Adult Solid Tumor, Protocol Specific 9Solid Tumors 9Advanced Solid Tumors 8Carcinoma, Non-Small-Cell Lung 7Small Cell Lung Carcinoma 6Retinoblastoma 5Advanced Solid Tumor 5Solid Tumor, Adult 4Lung Neoplasms 3Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Pleural Effusion, Malignant 2Ovarian Neoplasms 2Neoplasms 2Metastatic Solid Tumors 2Melanoma 2Carcinoma, Renal Cell 2Carcinoma 2Anus Neoplasms 2Xerophthalmia 1Vulvar Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Unspecified Adult Solid Tumor 1Triple Negative Breast Neoplasms 1Trachoma 1

Interventions

Imatinib Mesylate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Metastatic Solid Tumors. × Other solid neoplasm × Clear all
NCT00159016 2011-04-28

Role of Glivec in Patients With Tumor Cells Positive for C-kit or PDGFR; a Multi Center Study.

Hadassah Medical Organization

Phase 2 Withdrawn
100 enrolled
Other solid neoplasm

Metastatic Solid Tumors.

Data powered by HemOnc (CC BY 4.0) Colophon âš¡